Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -42.3% | +171.4% | 1 / 3 | -51.5% | +5.79 pp | +0.05 pp | +7.9% | 0.52 | 7.08 | 121 | −51,5% | 4,6 | −50,9% | 7.08 | 14.78 | −52,1% |
| Pts | 0 | 12 | 4 | 0 | 12 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 8.700 (close price on 2026-10-19)EPS (TTM): 1.228
Financial charts
1.Revenue & growth
VND bn121Q2/26
1.Revenue & growth
VND bn121Q2/26
2.Profit & growth
VND bn3,34Q2/26
3.Profit mix (Penman)
VND bn93,9Q2/26
4.Margins & cost structure
%26.3%Q2/26
5.Returns & cash cycle
% · days8.9%Q2/26
6.Earnings quality & cash
VND bn43,5Q2/26
7.Asset structure
VND bn2.199Q2/26
8.Funding & debt health
VND bn · times2.199Q2/26
9.Revenue backlog
VND bn348Q2/26
10.Valuation
times · %7,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %81Q2/26
Adjusted EPS growth, latest quarter
-42.3%
Average adjusted EPS growth, 3 quarters
-64.7%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26